Abdominal and pelvic malignant tumors
Conditions
Interventions
Control group:None
Intervention Group:On the basis of the Bifidobacterium triple viable capsule group oral administration of Gegen Qinlian Tang with additions and subtractions is used
Combination drug intervention group:On the basis of the Bifidobacterium triple viable capsule group oral administration of Gegen Qinlian Tang with additions and subtractions is used
Sponsors
Jiujiang First People's Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: (1) Age greater than 18 years and less than 80 years; (2) All patients have been diagnosed with malignant tumors through cytological or pathological examinations and are candidates for abdominal or pelvic radiotherapy according to the guidelines; (3) Conscious and thinking clearly with good communication skills; (4) Family members and patients have been informed and are willing to cooperate with the experiment and have signed an informed consent form.
Exclusion criteria
Exclusion criteria: (1) Patients with a history of severe intestinal diseases including ischemic bowel disease ulcerative colitis Crohn's disease etc.; (2) Those who have received antibiotic treatment within the past 2 years; (3) Patients with severe liver and kidney dysfunction. (4) Those with other major illnesses who cannot cooperate with the experiment or who withdraw midway; (5) Individuals unwilling to disclose medical records or with incomplete information.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Acute Radiation Injury Grading Criteria / RTOG/EORTC Grading; | — |
Countries
China
Contacts
Public ContactLingzhi Zeng
Jiujiang First People's Hospital
Outcome results
None listed